beta

AGRX

Agile Therapeutics, Inc.

Agrx

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.

Market Cap: 118 Million

Primary Exchange: NASDAQ

Website: http://www.agiletherapeutics.com

Shares Outstanding: 59.3 Million

Float: 48.7 Million

Dividend: (%)

Beta: 0.845959319413365

Sector: Health Technology

Industry: Pharmaceuticals: Other

Ethical Flags

Animal testing

Longest drawdown: 1269 trading days

From: 2015-04-16 To: 2019-12-09

Lowest Point:

Roth likes Village Farms in premarket analyst action

via: SeekingAlpha at 2019-06-13 03:36:02:000

Argenx (NASDAQ: AGRX ) initiated with Buy rating and 140 (28% upside) price target at Kepler Cheuvreux. More news on: Agile Therapeutics, Inc., Village Farms International, Inc., Savara Inc., Healthcare stocks news, Stocks on the move, , Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud